Wednesday, December 19, 2012

Reuters: Health News: Oncothyreon lung cancer drug fails in late-stage trial

Oncothyreon lung cancer drug fails in late-stage trial

(Reuters) - Biopharmaceutical company Oncothyreon Inc said a late-stage trial of its experimental lung cancer drug did not meet the main study goal of...

Source: http://goo.gl/mag/gVzUMfD


No comments:

Post a Comment

Subscribe Now: Feed Icon